Specialized Medical Company (TADAWUL:4019)
13.30
-0.42 (-3.06%)
Oct 15, 2026, 3:19 PM AST
TADAWUL:4019 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, TADAWUL:4019 stock has a consensus rating of "Buy" and an average price target of SAR 22.67. The average 1-year stock price forecast is 70.45% higher than the current stock price, while the lowest is SAR 17.00 (+27.82%) and the highest is SAR 30.00 (+125.56%).
Price Target: SAR 22.67 (+70.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4019 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Financial Forecast
Revenue This Year
1.69B
from 1.54B
Increased by 10.08%
Revenue Next Year
1.79B
from 1.69B
Increased by 5.74%
EPS This Year
0.93
EPS Next Year
1.11
from 0.93
Increased by 19.24%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.